Company profile
Sapience Therapeutics, Inc.
Changing the Tide to Achieve the Unachievable
- Industry
- Biotechnology Research
- Employees
- 23
- Headquarters
- Tarrytown, New York
- Founded
- 2015
- LinkedIn followers
- 4,263
- Office locations
- 1
Sapience Therapeutics, Inc. company summary
Sapience Therapeutics, Inc. is a company in the Biotechnology Research industry, headquartered in Tarrytown, New York, founded in 2015. On LinkedIn the company has around 23 employees and 4,263 followers. Its listed specialties include Biotechnology and Peptides.
What technology does Sapience Therapeutics, Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Sapience Therapeutics, Inc.
At Sapience, we think boldly about the possibilities for treating cancer. We aim to discover and develop peptide therapeutics to address oncogenic and immunogenic dysregulation that drive cancer. Our pipeline of SPEARs™ (Stabilized Peptides Engineered Against Regulation) disrupt intracellular protein-protein interactions, enabling targeting of transcription factors which have traditionally been considered undruggable. We are advancing our lead programs, ST316, a first-in-class antagonist of β-catenin, and lucicebtide (formerly known as ST101), a first-in-class antagonist of C/EBPβ, through Phase 2 clinical trials. Please engage with us on this platform to learn more!
Specialties
Where is Sapience Therapeutics, Inc. located?
Sapience Therapeutics, Inc. lists 1 location.
Compare companies similar to Sapience Therapeutics, Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Sapience Therapeutics, Inc. sapiencetherapeutics.com | Biotechnology Research | 23 | 2015 | Tarrytown, New York |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Sapience Therapeutics, Inc.
What does Sapience Therapeutics, Inc. do?
At Sapience, we think boldly about the possibilities for treating cancer. We aim to discover and develop peptide therapeutics to address oncogenic and immunogenic dysregulation that drive cancer. Our pipeline of SPEARs™ (Stabilized Peptides Engineered Against Regulation) disrupt intracellular protein-protein interactions, enabling targeting of transcription factors which have traditionally been considered undruggable. We are advancing our lead programs, ST316, a first-in-class antagonist of β-catenin, and lucicebtide (formerly known as ST101), a first-in-class antagonist of C/EBPβ, through Phase 2 clinical trials. Please engage with us on this platform to learn more!
How many employees does Sapience Therapeutics, Inc. have?
Sapience Therapeutics, Inc. has around 23 employees on LinkedIn.
Where is Sapience Therapeutics, Inc. headquartered?
Sapience Therapeutics, Inc. is headquartered in Tarrytown, New York.
When was Sapience Therapeutics, Inc. founded?
Sapience Therapeutics, Inc. was founded in 2015.
Build a lead list from companies like Sapience Therapeutics, Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.